Shiqin Liuمشاهده پروفایل
استادیار مدعو
Shiqin Liu is an Assistant Adjunct Professor at the University of California, Los Angeles (UCLA) in the Department of Molecular and Medical Pharmacology. As a clinician-scientist with translational focus, their work bridges clinical practice and cancer research through biomarker development and therapeutic innovation. MD, Central South University (2012) PhD in Oncology, Peking University (2017) Joint PhD, University of Miami (2016) Residency in Surgery, Central South University (2019) Postdoctoral Fellow, Stanford University (2019-2023) Postdoctoral Fellow, UCLA (2023) Their research focuses on identifying molecular drivers of cancer progression and developing clinical-grade diagnostic tools and therapies. Key areas include: Proteomics-based biomarker discovery for high-risk cancers Antibody-targeted therapies and imaging agents Mechanistic studies of neuroendocrine prostate cancer 3D tumor modeling and optical diagnostics Recent publications highlight their work on: Trop2 as a prognostic urinary biomarker for prostate cancer UCHL1's dual role in tumor growth and therapeutic targeting Novel drug targets like CDC7 and CXCR4/CB2 heterodimers Biofabrication techniques for cancer modeling Laboratory affiliations include: Stoyanova Lab at UCLA (2023-present) Stoyanova Lab at Stanford University (2019-2023)








